Metro Healthcare Indonesia Tbk. vs Phapros Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Phapros Tbk. trades at Rp256 (market cap 211.68B, 116.4K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 67.2× Phapros Tbk.'s market cap, and Metro Healthcare Indonesia Tbk. is more actively traded (346.3K versus 116.4K). Which is the better fit depends on your goals.
| CARE | PEHA | |
|---|---|---|
Market Cap | 14.23T | 211.68B |
Volume | 346.3K | 116.4K |
Lot | 3.46K | 1.16K |
Turnover | 147.93M | 29.27M |
Average Price | 427.18 | 251.47 |
Value | 147.93M | 29.27M |
Indicative Equilibrium Price | 428 | 256 |
Indicative Equilibrium Volume | 10 | 20 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →